Skip to main content
    L

    LifeMD Inc (LFMD)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $2.37
    -0.10 (-4.05%)

    Market Cap: $119.19M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    58%(14/24)
    Avg Surprise
    -38.02%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.01
    Range$-0.02 - $0.01
    2 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$0.17-102.9%
    60d ago$0.17-102.9%
    30d ago$0.17-102.9%
    7d ago$0.17-102.9%
    Current$-0.01
    Revenue Consensus
    $49M
    Range$46M - $51M
    8 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.01
    Range$-0.04 - $0.07
    2 analysts
    Revenue Consensus
    $61M
    Range$59M - $64M
    8 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.01---
    Sep 26EST
    		-$-0.01---
    Jun 26
    Reported Aug 5
    		$-0.16$-0.20+20.00%Beat-1500.0%
    Mar 26
    Reported May 6
    		$-0.15$-0.12-29.91%Miss-605.3%
    Dec 25
    Reported Mar 9
    		$0.06$0.09-33.33%Miss-71.4%
    Sep 25
    Reported Nov 17
    		$-0.08$0.05-260.00%Miss-188.9%
    Jun 25
    Reported Aug 4
    		$-0.01N/A-105.56%Miss-116.7%
    Mar 25
    Reported May 6
    		$0.03N/A-78.57%Miss+200.0%
    Dec 24
    Reported Mar 10
    		$0.21$0.14+50.00%Beat+275.0%
    Sep 24
    Reported Nov 7
    		$0.09$0.07+28.57%Beat+12.5%
    Jun 24
    Reported Aug 7
    		$0.06$0.04+50.00%Beat+20.0%
    Mar 24
    Reported May 8
    		$0.01$-0.01+200.00%Beat+106.7%
    Dec 23
    Reported Mar 11
    		$-0.12$-0.14+14.29%Beat+70.0%
    Sep 23
    Reported Nov 8
    		$0.08$0.03+166.67%Beat+366.7%
    Jun 23
    Reported Aug 9
    		$0.05$0.03+66.67%Beat+122.7%
    Mar 23
    Reported May 12
    		$-0.15$-0.16+6.25%Beat+67.4%
    Dec 22
    Reported Mar 22
    		$-0.40$-0.18-122.22%Miss-37.9%
    Sep 22
    Reported Nov 10
    		$-0.03N/A+75.00%Beat+91.7%
    Jun 22
    Reported Aug 11
    		$-0.22$-0.23+4.35%Beat+56.9%
    Mar 22
    Reported May 13
    		$-0.46$-0.36-27.78%Miss+4.2%
    Dec 21
    Reported Mar 7
    		$-0.29$-0.39+25.64%Beat+88.7%
    Sep 21
    Reported Nov 10
    		$-0.36$-0.49+26.53%Beat+65.0%
    Jun 21
    Reported Aug 12
    		$-0.51$-0.45-13.33%Miss+79.9%
    Mar 21
    Reported May 13
    		$-0.48$-0.44-9.09%Miss-118.2%
    Dec 20
    Reported Mar 29
    		$-2.56$-0.24-966.67%Miss-3557.1%
    Sep 20
    Reported Nov 16
    		$-1.03$-1.03+0.00%Beat-1044.4%
    Jun 20
    Reported Aug 14
    		$-2.54N/AN/ABeat-2809.5%
    Mar 20
    Reported May 19
    		$-0.22N/AN/ABeat-210.3%
    Dec 19
    Reported Mar 30
    		$-0.07N/AN/ABeat+17.7%
    Sep 19
    Reported Nov 14
    		$-0.09N/AN/ABeat-61.3%
    Jun 19
    Reported Aug 14
    		$-0.09N/AN/ABeat-24.2%
    Mar 19
    Reported May 15
    		$-0.07N/AN/ABeat-204.6%
    Dec 18
    Reported Mar 29
    		$-0.09N/AN/ABeat-240.4%
    Sep 18
    Reported Nov 14
    		$-0.06N/AN/ABeat+27.4%
    Jun 18
    Reported Aug 17
    		$-0.07N/AN/ABeat-190.1%
    Mar 18
    Reported Apr 2
    		$0.07N/AN/ABeat+148.8%
    Dec 17
    Reported Dec 31
    		$-0.03N/AN/ABeat+71.5%
    Sep 17
    Reported Nov 14
    		$-0.08N/AN/ABeat-
    Jun 17
    Reported Jul 7
    		$0.08N/AN/ABeat-
    Mar 17
    Reported Mar 31
    		$-0.14N/AN/ABeat-
    Dec 16
    Reported Dec 31
    		$-0.09N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-7.15EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.11%Operating Margin-15.10%
    ROE-516.00%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio0.90xQuick Ratio0.84x
    Trading Statistics
    Beta1.99Avg Volume722.42K
    52-Week High$6.4352-Week Low$2.36

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$2.65
    SMA 20$2.85
    SMA 50$3.10
    SMA 200$3.76
    EMA 10$2.63
    EMA 20$2.79
    EMA 50$3.13
    EMA 200$4.00

    MACD

    Line: -0.20Signal: -0.16Hist: -0.03

    ADX

    ADX: 36.3+DI: 8.5-DI: 30.9

    Aroon & PSAR

    Aroon Up12.0
    Aroon Down100.0
    PSAR$2.76

    Bollinger Bands

    Upper Band$3.37
    Lower Band$2.34
    %B Position3623%(Upper)
    Band Width0.03

    RSI (14-Day)

    Oversold
    24.6

    Momentum Oscillators

    Stoch %K2.2
    Stoch %D3.4
    Williams %R-97.8
    ROC (10d)-18.3%
    Momentum-0.53
    CCI (20d)-154.8
    MFI (14d)21.9

    Volatility Measures

    ATR (14d)$0.15(6.5%)
    StdDev (20d)0.26
    Hist Vol42.3%(High)

    Volume Flow

    VWAP$2.40
    OBV6.3M
    AD Line-12.8M
    CMF (20d)-0.459

    Volume Metrics

    Avg Vol (20d)715.6K
    Vol Ratio0.9x
    VWMA (20d)$2.86

    Pivot Points

    R3$2.65
    R2$2.61
    R1$2.54
    Pivot Point$2.50
    S1$2.43
    S2$2.39
    S3$2.32

    Advanced Oscillators

    TSI-35.11
    Ultimate Osc29.4
    KST-158.44

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$47.28M$50.16M$46.87M$60.17M$49.02M$50.89M$64.25M$53.27M$50.66M$44.14M$44.86M$38.61M
    Cost of Revenue$5.28M$5.93M$8.52M$7.41M$6.84M$8.14M$9.43M$5.01M$5.02M$4.60M$5.36M$4.78M
    Gross Profit$42.00M$44.24M$38.35M$52.76M$42.18M$42.75M$54.82M$48.26M$45.64M$39.54M$39.50M$33.83M
    Operating Expenses$49.13M$53.17M$39.45M$54.73M$44.53M$43.93M$53.81M$52.26M$51.94M$45.72M$41.68M$38.40M
    R&D$1.79M$1.80M$1.82M$2.85M$1.82M$1.86M$2.41M$2.61M$2.40M$2.09M$2.00M$1.50M
    SG&A$19.30M$21.50M$15.54M$22.41M$20.55M$19.80M$25.54M$23.03M$23.16M$19.45M$19.29M$17.13M
    Operating Income$-7,129,601$-8,929,072$-1,097,718$-1,969,214$-2,346,886$-1,181,717$1.02M$-3,996,274$-6,305,566$-6,171,245$-2,171,536$-4,569,381
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$-45,660$-56,476$190,791$1.42M$660,787$463,638$614,074$558,597$531,468$477,678$622,685$713,766
    Income Before Tax$-7,083,941$-8,872,596$-1,073,639$-3,387,521$-3,007,673$-1,645,355$404,168$-4,554,871$-6,837,034$-6,648,923$-2,794,221$-5,283,147
    Income Tax Expense$0$0$13,898$169,134$0$0$0$232,523$0$0$0$0
    Net Income$-7,083,941$-8,872,596$-1,496,800$-3,556,655$-1,114,589$348,067$234,691$-4,787,394$-6,837,034$-6,648,923$-3,222,221$-5,283,147
    EBITDA$-5,091,217$-6,932,845$876,088$1.06M$-461,097$610,135$3.67M$-1,338,914$-3,916,897$-3,971,516$-130,364$-2,754,859
    EBIT$-7,129,601$-8,929,072$-1,073,639$-1,969,214$-2,346,886$-1,181,717$1.02M$-3,996,274$-6,305,566$-6,171,245$-2,171,536$-4,569,381
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about LFMD

    News

    How Lifemd Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) Affects Rotational Strategy Timing

    This article analyzes Lifemd Inc.'s (LFMDP) preferred stock, noting a neutral sentiment across all time horizons and an exceptional 11.3:1 risk-reward setup. It outlines three AI-generated institutional trading...

    Stock Traders Daily•10/7/26•Neutral

    LifeMD (LFMD) Secures AT&T Partnership. Can Free Memberships Produce Paying Patients?

    LifeMD (LFMD) recently announced a partnership with AT&T, offering free telehealth memberships to eligible AT&T customers. While this could significantly expand LifeMD's subscriber base...

    AlphaStreet•9/21/26•Neutral

    H.C. Wainwright reiterates LifeMD stock rating on AT&T deal By Investing.com

    H.C. Wainwright has reiterated a Buy rating and a $9.00 price target for LifeMD Inc. following its exclusive collaboration announcement with AT&T. This partnership offers eligible AT&T customers a complimentary LifeMD...

    Investing.com Nigeria•9/18/26•Neutral

    H.C. Wainwright reiterates LifeMD stock rating on AT&T deal By Investing.com

    H.C. Wainwright maintained a Buy rating and a $9.00 price target for LifeMD Inc. following its exclusive partnership announcement with AT&T. This collaboration offers eligible AT&T customers a complimentary LifeMD...

    Investing.com Canada•9/18/26•Somewhat-Bullish

    Form 8K LifeMD Inc For: 15 September By Investing.com

    This article briefly reports on the filing of a Form 8K by LifeMD Inc. on September 15. The content includes the company's stock symbol (LFMD) and its immediate price performance. The main focus is the notification...

    Investing.com Canada•9/15/26•Neutral

    LFMD Valuation and Fair Value

    P/E
    -7.1x
    Forward P/E
    12.8x
    P/B
    14.2x
    See GNG's fair value

    LFMD Profitability: Margins, ROIC and FCF

    Operating margin
    -15.1%
    Net margin
    0.1%
    ROE
    -516.0%

    LFMD Competitors

    CompanyTicker
    Fonar CorporationFONR
    Tenaya Therapeutics IncTNYA
    NyxoahNYXH
    Seer IncSEER
    MaxCyte IncMXCT
    Cassava Sciences IncSAVA
    OrganiGram Holdings IncOGI
    OUTLOOK THERAPEUTICS INCOTLK

    Sector: Healthcare

    LFMD Analyst Ratings

    Consensus
    Buy
    Analysts
    8
    Strong Buy
    0
    Buy
    8
    Hold
    0
    Sell
    0
    Strong Sell
    0

    LFMD Bull Case vs Bear Case

    Bull case

    • 100.0% of LFMD's analyst ratings are Buy or Strong Buy.

    Bear case

    • LFMD beat EPS estimates in 37.5% of its last 8 reported quarters.
    • LFMD's quarterly revenue changed -3.5% year over year.

    LFMD Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -51.1%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.01
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 1 down

    Frequently Asked Questions About LFMD

    Does LFMD pay dividends?

    LifeMD Inc (LFMD) does not currently pay a regular dividend.

    What is LFMD's market cap?

    LifeMD Inc (LFMD) has a market capitalization of $119.19M with a current stock price of $2.37.

    Related stocks

    Sector: Healthcare

    All stocks starting with L

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In